Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2518 Views
-
Last post by NHE
-
- 6 Replies
- 7099 Views
-
Last post by ElliotB
-
- 0 Replies
- 1412 Views
-
Last post by NHE
-
- 0 Replies
- 3731 Views
-
Last post by NHE
-
- 1 Replies
- 1128 Views
-
Last post by NHE
-
- 1 Replies
- 1680 Views
-
Last post by NHE
-
- 11 Replies
- 3517 Views
-
Last post by NHE
-
- 0 Replies
- 3435 Views
-
Last post by NHE
-
- 0 Replies
- 1593 Views
-
Last post by NHE